Page 12 - அமெரிக்கன் சமூகம் க்கு கதிர்வீச்சு புற்றுநோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stereotactic ablative radiotherapy for early stage lung cancer and lung metastases in a New Zealand population Open Access PDF Download Stereotactic ablative radiotherapy (SABR) involves the delivery of high doses of precisely targeted external beam radiation in a shorter time period and with fewer treatments than conventional radiotherapy. Leksell first described the concept of stereotactic radiosurgery in 1951.1 Initially, however, its use was restricted to intracranial targets. With advancements in linear accelerator technology, the use of stereotactic techniques was expanded to extracranial targets in the 1990s.2 Lung cancer remains the leading cause of cancer death in New Zealand.3 Only 16.5% of lung cancer in New Zealand is diagnosed at an early stage. Māori patients are more likely to be diagnosed at a later stage4,5 and less likely to receive curative surgery than non-Māori patients.6 Early international studies investigating the use of SABR for inoperable patients wit

New zealandNew zealand generalUnited statesAmerican society for radiation oncologyAmerican societyRadiation oncologyபுதியது ஜீலாந்தும ori ரிபுதியது ஜீலாந்து ஜநரல்ஒன்றுபட்டது மாநிலங்களில்அமெரிக்கன் சமூகம் க்கு கதிர்வீச்சு புற்றுநோயியல்அமெரிக்கன் சமூகம்கதிர்வீச்சு புற்றுநோயியல்